Abstract
Cancers of unknown primary (CUPs) are a heterogeneous group of cancers, characterized by its main clinical symptom, which consists of metastasis without an identifiable primary tumor. Certain prognostic markers can contribute to the treatment of patients who do not respond well to conventional treatments, because they can be potential targets for the development of new therapies. In this …